We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS Cancels $877.5 Million VaxGen Anthrax Vaccine Contract
HHS Cancels $877.5 Million VaxGen Anthrax Vaccine Contract
January 3, 2007
VaxGen said that HHS has terminated for default the company’s $877.5 million contract to provide 75 million doses of a modern anthrax vaccine for civilian biodefense.